Latest

major depressive disorder

·November 4, 2020·5 min read

Psychedelic Treatment With Psilocybin Relieves Major Depression

Two doses of psilocybin in combination with therapy rapidly and significantly reduces symptoms in those with major depressive disorder. The effects appear to last for up to four weeks.

Featured Neurology

·August 19, 2020·3 min read

Is Risk of Alzheimer’s Linked to Specific Sleep Patterns?

Sleep disturbances may be an outcome of Alzheimer's in those with a genetic predisposition, but not a cause of dementia. Those with genetic risk factors for Alzheimer's tend to have shorter sleep durations and are more likely to be early risers but are less likely to suffer from insomnia.

Featured Psychology

·July 31, 2020·4 min read

Major Depressive Episodes Far More Common Than Previously Believed

Study reports that almost 30% of women and 17% of men experience major depressive disorder episodes over the course of their lives.

Featured Psychology

·July 15, 2020·4 min read

Early Life Stress Associated with Youth Onset of Depression for Some Types of Stress But Not Others

Examining the impact of eight types of early life stress on the onset of youth-onset depression, researchers found some had little impact on the development of the psychological disorder. Emotional abuse was more strongly associated with the development of major depressive disorder than other early stressors, such as poverty.

Featured Genetics Neuroscience Psychology

·June 11, 2020·3 min read

Adult stem cell study shows fish oil may help with depression

Using patient-derived adult stem cells, researchers found fish oil created an antidepressant response.

Featured Neuroscience Psychology

·April 23, 2020·5 min read

Natural mood regulation low or even absent in people with depression

During periods where personal choices of activities are constrained, natural mood regulation becomes impaired, resulting in an increased risk of depression.

Featured Neuroscience Open Neuroscience Articles Psychology

·March 20, 2020·3 min read

New drug can ease the side effects of medication against severe depression

A new substance named Lu AF60097 may help reduce side effects from tricyclic antidepressants in those with severe depression.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·March 9, 2020·7 min read

The largest genetic map of psychiatric disorders so far

The largest genetic map of mental health disorders to date reveals there are three groups of highly genetically related disorders among eight psychiatric disorders. A gene related to nervous system development is a risk factor for all eight disorders studied. The RBFOX1 gene is implicated in seven of the eight disorders. ADHD and depression share 44% of genetic risk factors common in the general population. 109 pleiotropic loci affect more than one disorder. These pleiotropic loci are within genes that show heightened expression in the brain through the lifespan, beginning during the second trimester of pregnancy.

Featured Neuroscience Psychology

·February 20, 2020·6 min read

Decision time predicts the risk of depression relapse

Findings reveal it is possible to predict the risk of a person with MDD lapsing back into depression after stopping antidepressants. Those who relapse take longer to decide how much effort to invest for a reward.

Featured Genetics Neuroscience Psychology

·February 12, 2020·5 min read

Multi-center neuroimaging study offers new insights on schizophrenia

Those with 22q11.2 deletion syndrome had significantly lower brain volume, as well as lower volumes in specific structures, including the thalamus, hippocampus, and amygdala.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 7, 2020·4 min read

New biochemical ‘warning sign’ of early-stage depression identified

High levels of anthranilic acid in the blood may be a new biomarker for assessing the risk of developing major depressive disorder.

Featured Neuroscience Open Neuroscience Articles Psychology

·December 26, 2019·7 min read

Early-life exposure to dogs may lessen risk of developing schizophrenia

Exposure to household pet dogs in the early years of life was associated with a significantly decreased risk of being diagnosed with schizophrenia later in life.

1 2 3 4 5 6 … 11

major depressive disorder

Psychedelic Treatment With Psilocybin Relieves Major Depression

Is Risk of Alzheimer’s Linked to Specific Sleep Patterns?

Major Depressive Episodes Far More Common Than Previously Believed

Early Life Stress Associated with Youth Onset of Depression for Some Types of Stress But Not Others

Adult stem cell study shows fish oil may help with depression

Natural mood regulation low or even absent in people with depression

New drug can ease the side effects of medication against severe depression

The largest genetic map of psychiatric disorders so far

Decision time predicts the risk of depression relapse

Multi-center neuroimaging study offers new insights on schizophrenia

New biochemical ‘warning sign’ of early-stage depression identified

Early-life exposure to dogs may lessen risk of developing schizophrenia

Dual Brain-Machine Interfaces Unlock Bionic Hand Kinesthesia

Overcoming Endothelial Sorting to Cure Glioblastoma

Hybrid VR and Nerve Stimulation Doubles Stroke Recovery

150-Year-Old Neuroanatomy Mystery Confirmed via MRI

Subscribe